A case of Pulmonary Inflammatory Fibroblastic Tumor with Clinical, Radiological, Histopathological Features and 2-year follow-up Results and Review of the Literature

Inflammatory myofibroblastic tumor (IMT) is a mesenchymal neoplasm. So in any organ, IMT hasthe potential of development. The most common sites that it arises are the lungs. It can occur in anyage, but predominantly in children and adolescents. The etiology is not known. It is poorly understoodon genetic and molecular level either. Clinical symptoms and radiological features are nonspecific inpulmonary IMT, can imitate lung cancer or tuberculosis. Diagnosis is based on histopathologic or immunohistochemical evaluation. The biological behavior is highly unpredictable, rarely metastase, frequently re-occure. Therapeutic approach rely mainly on complete surgical resection although there isno guideline for the treatment or follow-up. Here in, we report a pulmonary IMT case with clinical,radiological, histopathological features, and 2 year follow up results after complete surgical resection.

PDF

___

1. Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol 1995;19(8):859–72.
2. Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol 2008;61(4):428–37.
3. Griffin CA, Hawkins AL, Dvorak C, Henkle C, Ellingham T, Perlman EJ. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res 1999;59(12):2776–80.
4. Mahale A, Venugopal A, Acharya V, Kishore M, Shanmuganathan A, Dhungel K. Inflammatory myofibroblastic tumor of lung. Indian J Radiol Imag 2006;16(2):207–10.
5. Cerfolio RJ, Allen MS, Nascimento AG, Deschamps C, Trastek VF, Miller DL, et al. Inflammatory pseudotumors of the lung. Ann Thorac Surg. 1999;67(4):933–6.
6. Su LD, Atayde-Perez A, Sheldon S, Fletcher JA, Weiss SW. Inflammatory myofibroblastic tumor: cytogenetic evidence supporting clonal origin. Mod Pathol 1998;11(4):364–8.
7. Barbetakis N, Efstathiou A, Xenikakis T, Konstantinidis H, Fessatidis I. An unusual cause of haemoptysis in a young male. Int Sem Surg Oncol 2006;3:6.
8. Nevhauser TS, Ddrringer GA, Thomson LD, Fanburg-smith JC, Aguillera NS, Andriko J, et al. Splenic inflammatory miofibroblastic tumor (Inflammatory Pseudotumor): a clinicalpathologig and immunophenotypic study of 12 cases. Arch Pathol Lab Med 2001;125(3):379–85.
9. Meis JM, Enzinger FM. Inflammatory fibrosarcoma of the mesentery and retroperitoneum. A tumor closely simulating inflammatory pseudotumor. Am J Surg Pathol 1991;15(12):1146–56.
10.Kazantseva IA, Gurevich LE, Stepanova EV. Extrapulmonary inflammatory myofibroblastic tumor. [Article in Russian] Arkh Patol 2001;63(6):35–9.
11.Narla LD, Newman B, Spottswood SS, Narla S, Kolli R. Inflammatory pseudotumor. RadioGraphics 2003;23(3):719–29.
12.Sanders BM, West KW, Gingalewski C, Engum S, Davis M, Grosfeld JL. Inflammatory pseudotumor of the alimentary tract: clinical and surgical experience. J Pediatr Surg 2001;36(1):169–73.
13.World Health Organization. WHO Classification of Tumours of Soft Tissue and Bone IARC WHO Classification of Tumours. 3rd edition. Lyons: France: World Health Organization; 2013.
14.Melloni G, Carretta A, Ciriaco P, Arrigoni G, Fieschi S, Rizzo N, et al. Inflammatory pseudotumor of the lung in adults. Ann Thorac Surg 2005;79(2):426–32.
15.Cohen MC, Kaschula RO. Primary pulmonary tumors in childhood: a review of 31 years’ experience and the literature. Pediatr Pulmonol 1992;14(4):222–32.
16.Bonnet JP, Basset T, Dijoux D. Abdominal inflammatory myofibroblastic tumors in children: report of an appendiceal case and review of the literature. J Pediatr Surg 1996;31(9):1311–4.
17.Bando T, Fujimura M, Noda Y, Hirose J, Ohta G, Matsuda T. Pulmonary plasma cell granuloma improves with corticosteroid therapy. Chest 1994;105(5):1574–5.
18.Kovach SJ, Fischer AC, Katzman PJ, Salloum RM, Ettinghausen SE, Madeb R, et al. Inflammatory myofibroblastic tumors. J Surg Oncol 2006;94(5):385–91.
19.Lee HJ, Kim JS, Choi YS, Kim K, Shim YM, Han J, et al. Treatment of inflammatory myofibroblastic tumor of the chest: the extent of resection. Ann Thorac Surg 2007;84(1):221–4.
20.Butrynski JE, D’Adamo DR, Hornick JL, Dal Cin P, Antonescu CR, Jhanwar SC, et al. Crizotinib in ALKrearranged inflammatory myofibroblastic tumor. N Engl J Med. 2010;363(18):1727–33.